Onglyza 2.5 mg Film-Coated Tablets

Company:
AstraZeneca Pharmaceuticals (Ireland) DAC
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may be renewed (B)
Active Ingredient(s):
Saxagliptin Hydrochloride
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/09/545/011

2.5 milligram(s)

A10BH03

Film-coated tablet

EU/1/09/545/012

2.5 milligram(s)

A10BH03

Film-coated tablet

EU/1/09/545/013

2.5 milligram(s)

A10BH03

Film-coated tablet

EU/1/09/545/014

2.5 milligram(s)

A10BH03

Film-coated tablet

EU/1/09/545/015

2.5 milligram(s)

A10BH03

Film-coated tablet

Product Notice

Supply of Onglyza 2.5 mg Film-Coated Tablets to the Irish market will be discontinued by July 2024.